Simplify Logo

Full-Time

Global Corporate Controller

Posted on 6/27/2024

ReCor Medical

ReCor Medical

201-500 employees

Develops ultrasound technology for hypertension treatment

Biotechnology
Healthcare

Compensation Overview

$240k - $270kAnnually

Expert

Palo Alto, CA, USA

Category
Financial Controller
Accounting
Requirements
  • CPA license or international equivalent
  • MBA is a plus
  • 15+ years of relevant experience
  • High competence in all areas of accounting and financial reporting
  • International experience in accounting for companies with multiple foreign subsidiaries
  • Ability to design, implement, and document internal controls
  • Expert knowledge of accounting standards, especially ASC 606 / IFRS 15
  • Strong management skills
  • Excellent organizational skills and attention to detail
  • Collaborative team player
  • COVID-19 vaccination requirements
Responsibilities
  • Manage day-to-day accounting operations
  • Develop and implement process improvements across all accounting activities
  • Own the financial close process and preparation of financial statements
  • Grow the European accounting team
  • Coordinate with an outsourced tax provider
  • Manage an accounting staff
  • Perform system implementations/enhancements
  • Conduct initial research of accounting issues

ReCor Medical focuses on treating hypertension, a condition that affects over 1 billion people globally. The company has created the Paradise System, which utilizes non-focused ultrasound technology to perform renal denervation, a procedure that targets kidney nerves to help lower blood pressure. This system is particularly beneficial for patients who do not respond well to standard blood pressure medications. ReCor Medical is dedicated to clinical research and development to ensure the safety and effectiveness of its technology, and it generates revenue through the sale of its medical devices and partnerships with healthcare providers. The company is also involved in significant clinical trials, such as the RADIANCE Global Program, aimed at validating the benefits of renal denervation. ReCor Medical's goal is to provide a new treatment option for hypertension, addressing a major global health challenge.

Company Stage

Series D

Total Funding

$37.9M

Headquarters

Palo Alto, California

Founded

2009

Simplify Jobs

Simplify's Take

What believers are saying

  • The FDA approval of the Paradise System opens up substantial market opportunities in the U.S. for ReCor Medical.
  • ReCor Medical's commitment to innovation and early intervention in hypertension treatment can lead to significant advancements in patient outcomes.
  • Strategic leadership appointments, such as the new CEO from Siemens Healthineers, bring valuable expertise and direction for global commercialization.

What critics are saying

  • The high reliance on clinical trial outcomes for regulatory approvals can pose significant risks if results are unfavorable.
  • The competitive landscape in hypertension treatment, including potential advancements from larger medical device companies, could impact ReCor Medical's market share.

What makes ReCor Medical unique

  • ReCor Medical's Paradise System uses non-focused ultrasound technology for renal denervation, a unique approach in the hypertension treatment market.
  • The company's strong focus on clinical research, exemplified by the RADIANCE Global Program, sets it apart in validating the efficacy and safety of its technology.
  • ReCor Medical has achieved a significant milestone with FDA approval, positioning it ahead of competitors in the renal denervation space.
INACTIVE